Poseida Therapeutics Inc reports results for the quarter ended in September - Earnings Summary

Poseida Therapeutics

10/11/2021 22:00

* Poseida Therapeutics Inc  PSTX.OQ  reported a quarterly
adjusted loss of 68 cents​​ per share for the quarter ended in
September. The mean expectation of three analysts for the
quarter was for a loss of 74 cents per share.
* Reported revenue was zero​;  analysts expected zero. 
* Poseida Therapeutics Inc's reported EPS for the quarter was a
loss of 68 cents​.
* The mean earnings estimate of analysts had fallen by
about 21.9% in the last three months.​ 
* In the last 30 days one analyst negatively revised an earnings
estimate 
* Poseida Therapeutics Inc shares had fallen by 7.3% this
quarter and lost 38.4% so far this year.
* The company reported a quarterly loss of $42.42 million.
* Wall Street's median 12-month price target for Poseida
Therapeutics Inc is $20.00 
* The current average analyst rating on the shares is "strong
buy" and the breakdown of recommendations is 4 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 
This summary was machine generated November 10 at 10:00 p.m.
 ​All figures in US dollars unless otherwise stated